The Jerusalem Post FDA clears first US trial of Israel’s EndoArt synthetic corneal implant
EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment targeted to begin in March 2026.
EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment targeted to begin in March 2026.